Related Experiment Video
Updated: Aug 14, 2025

Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
A Novel Y-Shaped, S-O-N-O-S-Bridged Cross-Link between Three Residues C22, C44, and K61 Is Frequently Observed in the
Kai S Yang, Lauren R Blankenship, Syuan-Ting Alex Kuo
1Department of Biochemistry, Brandeis University, Waltham, Massachusetts 02453, United States.
Abstract:
As the COVID-19 pathogen, SARS-CoV-2 relies on its main protease (MPro) for pathogenesis and replication. During crystallographic analyses of MPro crystals that were exposed to the air, a uniquely Y-shaped, S-O-N-O-S-bridged post-translational cross-link that connects three residues C22, C44, and K61 at their side chains was frequently observed. As a novel covalent modification, this cross-link serves potentially as a redox switch to regulate the catalytic activity of MPro, a demonstrated drug target of COVID-19. The formation of this linkage leads to a much more open active site that can potentially be targeted for the development of novel SARS-CoV-2 antivirals. The structural rearrangement of MPro by this cross-link indicates that small molecules that lock MPro in the cross-linked form can potentially be used with other active-site-targeting molecules such as paxlovid for synergistic effects in inhibiting SARS-CoV-2 viral replication.
Insights
A novel cross-link in SARS-CoV-2 main protease (MPro) acts as a redox switch, opening the active site. This discovery offers new strategies for developing COVID-19 antivirals, potentially enhancing existing treatments.
Area of Science:
- Biochemistry
- Structural Biology
- Virology
Background:
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) utilizes its main protease (MPro) for replication and pathogenesis.
- MPro is a validated drug target for COVID-19 therapeutics.
Purpose of the Study:
- To investigate novel post-translational modifications of SARS-CoV-2 MPro.
- To explore the structural and functional implications of observed MPro cross-links.
Main Methods:
- Crystallographic analysis of MPro crystals exposed to ambient conditions.
- Structural determination of a novel Y-shaped, S-O-N-O-S-bridged cross-link involving C22, C44, and K61 residues.
Main Results:
- A unique Y-shaped post-translational cross-link was frequently observed in MPro.
- This cross-link connects Cys22, Cys44, and Lys61 residues via their side chains.
- Formation of the cross-link results in a more open MPro active site, suggesting a redox-switch mechanism.
Conclusions:
- The novel MPro cross-link may function as a redox switch, regulating protease activity.
- The altered active site conformation presents a new target for antiviral drug development.
- Small molecules stabilizing the cross-linked MPro could synergize with existing antivirals like Paxlovid to inhibit SARS-CoV-2 replication.
Related Concept Videos
Structural Protein Function
The Proteasome Structure
The proteasome is an...
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Single-Strand DNA Binding Proteins
Peptide Bonds
Protein Organization
The primary structure of a protein is its amino acid sequence....

